吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 29 2016

Full Issue

Despite Democrats' Previous Pharma Criticism, Convention Is A Schoomze Extravaganza For Industry

Curbing high drug prices is a popular topic on the campaign trail, but industry lobbyists weren't feeling the heat at the Democratic National Convention this week. Meanwhile, now that the general election is officially on, The Hill looks at what to expect out of the candidates' health care policies.

The drug industry didn鈥檛 really feel the heat here at the Democratic National Convention. Once you left Wells Fargo Arena, where Bernie Sanders thundered, 鈥淭he greed of the drug companies must end!鈥 in the climatic speech of the convention鈥檚 opening night, drug lobbyists could be seen chatting with senior Democratic officials in crowded bars, picking at spreads of choice charcuterie and cheese. In between band sets at one such event, cosponsored by the drug company Astellas, Democratic congressmen lauded free trade 鈥 on the same day that streams of Sanders supporters had chanted their opposition to the Trans-Pacific Partnership agreement. (Scott, 7/28)

Clinton would expand Obamacare by allowing a buy-in to Medicare starting at age 55, offering a public health insurance option and continuing the drive for Medicaid expansion...Mr. Trump has adopted the Republican platform, which eliminates Obamacare and replaces it with consumer-based insurance plans. (Bellefeuille, 7/28)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
  • Friday, July 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF